Found 10 matching trials
Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer
PHASE2RATIONALE: Drugs used in chemotherapy, such as carboplatin, irinotecan, and...
Location
University of Miami Sylvester Comprehensive Cancer Center
OPSCC N0 Nodal Control With Reduced IMRT
NAThe dose of radiation most commonly used to treat oropharyngeal cancer resu...
Location
University of Virginia Health System
Evaluation of Immune Responses and Outcomes in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy
N/ARadiation therapy is a highly effective modality for managing localized sol...
Location
Chang Gung Memorial Hospital at Linkou
Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma
PHASE2Atezolizumab (anti-programmed death-ligand 1; anti-PD-L1) in conjunction wi...
Location
Chang Gung Memorial Hospital at Linkou
Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer
PHASE1RATIONALE: Radiotherapy is currently the most efficient way to induce patho...
Location
Centre Hospitalier Universitaire Vaudois
Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma
PHASE2The aim of this study is the evaluate the feasibility and safety of chemoth...
Location
Landeskrankenhaus Feldkirch
Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects
PHASE3Primary objective: to assess the antitumor activity and safety profile of c...
Location
Fujian Provincial Tumor Hospital
Proton Therapy for Hodgkin Lymphoma
NAThe purpose of this study is to reduce the risk of radiation related side e...
Location
University of Florida Proton Therapy Institute
Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
PHASE2Tremelimumab plus durvalumab (the STRIDE regimen) is an approved first-line...
Location
Chang Gung Memorial Hospital at Linkou
Preoperative Radiation Therapy for High Risk Prostate Cancer
PHASE1This is a Phase I dose-escalation study of moderate dose radiation therapy ...
Location
Duke University Medical Center